FLS Stock Analysis: Flowserve | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 9.100m USD | 12M Return: 31.1% | US34354P1057 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 109M
EPS Trend: 98.8%
Qual. Beats: 1
Rev. Trend: 88.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Flowserve Corporation (NYSE: FLS) is a global industrial flow management company that designs, manufactures, distributes, and services pumps, valves, seals, and related equipment across the United States, Canada, Mexico, Europe, the Middle East, Africa, and Asia Pacific. The company operates through two segments: the Flowserve Pumps Division (FPD) and the Flow Control Division (FCD), offering custom engineered pumps, pre-configured industrial pumps, mechanical seals, isolation and control valves, valve automation products, and actuators. Its product portfolio includes proprietary brands such as Valtek, Argus, Worcester, Limitorque, and Durco.
The company provides a full range of lifecycle services, including installation, commissioning, advanced diagnostics, repair, retrofitting, and asset management, supporting customers in oil and gas, power generation, chemical, water management, and general industries such as pharmaceuticals, mining, food and beverage, steel, and pulp and paper. Flowserve distributes its products through direct sales, distributors, and sales representatives.
Flowserve is headquartered in Irving, Texas, and was founded in 1790. As a mid-cap industrial machinery company in the Industrials sector, it serves capital-intensive process industries where pumps, valves, and flow control equipment are critical operational components, particularly within oil and gas and power generation, which are traditionally cyclical end markets tied to global energy demand and capital spending.
- Oil and gas capex cycle drives pump and valve backlog
- Middle East energy infrastructure spending boosts FPD orders
- Margin expansion from operational efficiency and pricing actions
| Net Income: 371.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.51 > 1.0 |
| NWC/Revenue: 36.04% < 20% (prev 33.87%; Δ 2.17% < -1%) |
| CFO/TA 0.08 > 3% & CFO 487.8m > Net Income 371.3m |
| Net Debt (1.77b) to EBITDA (730.4m): 2.42 < 3 |
| Current Ratio: 2.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (128.4m) vs 12m ago -2.46% < -2% |
| Gross Margin: 35.09% > 18% (prev 33.12%; Δ 1.97% > 0.5%) |
| Asset Turnover: 77.22% > 50% (prev 81.76%; Δ -4.54% > 0%) |
| Interest Coverage Ratio: 7.53 > 6 (EBIT TTM 634.9m / Interest Expense TTM 84.4m) |
| A: 0.26 (Total Current Assets 3.12b - Total Current Liabilities 1.45b) / Total Assets 6.32b |
| B: 0.69 (Retained Earnings 4.39b / Total Assets 6.32b) |
| C: 0.11 (EBIT TTM 634.9m / Avg Total Assets 6.00b) |
| D: 0.57 (Book Value of Equity 2.26b / Total Liabilities 3.99b) |
| Altman-Z'' = 5.30 = AAA |
| DSRI: 1.01 (Receivables 1.40b/1.39b, Revenue 4.63b/4.65b) |
| GMI: 0.94 (GM 33.12% / 35.09%) |
| AQI: 1.12 (AQ_t 0.39 / AQ_t-1 0.34) |
| SGI: 1.00 (Revenue 4.63b / 4.65b) |
| TATA: -0.02 (NI 371.3m - CFO 487.8m) / TA 6.32b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of October 24, 2026, the stock is trading at USD 68.20 with a total of 1,363,485 shares traded. Over the past week, the price has changed by -3.29%, over one month by -11.38%, over three months by -4.55% and over the past year by +31.05%.
Current recommended Stop Loss: 64.80 (which is 5% or 1.3 ATR below the current price).
Flowserve has received a consensus analysts rating of 4.18. Therefore, it is recommended to buy FLS.
- StrongBuy: 6
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 87.6 | 28.4% |
P/E Trailing = 24.3503
P/E Forward = 16.5017
P/S = 1.9637
P/B = 4.3417
P/EG = 1.6509
Revenue TTM = 4.63b USD
EBIT TTM = 634.9m USD
EBITDA TTM = 730.4m USD
Long Term Debt = 2.12b USD (from longTermDebt, last quarter)
Short Term Debt = 50.1m USD (from shortTermDebt, last quarter)
Debt = 2.50b USD (from shortLongTermDebtTotal, last quarter) + Leases 183.2m
Net Debt = 1.77b USD (calculated: Debt 2.50b - CCE 731.0m)
Enterprise Value = 10.9b USD (9.10b + Debt 2.50b - CCE 731.0m)
Interest Coverage Ratio = 7.53 (Ebit TTM 634.9m / Interest Expense TTM 84.4m)
EV/FCF = 26.42x (Enterprise Value 10.9b / FCF TTM 411.4m)
FCF Yield = 3.78% (FCF TTM 411.4m / Enterprise Value 10.9b)
FCF Margin = 8.88% (FCF TTM 411.4m / Revenue TTM 4.63b)
Net Margin = 8.01% (Net Income TTM 371.3m / Revenue TTM 4.63b)
Gross Margin = 35.09% ((Revenue TTM 4.63b - Cost of Revenue TTM 3.01b) / Revenue TTM)
Gross Margin QoQ = 32.91% (prev 37.10%)
Tobins Q-Ratio = 1.72 (Enterprise Value 10.9b / Total Assets 6.32b)
Interest Expense / Debt = 3.37% (Interest Expense 84.4m / Debt 2.50b)
Taxrate = 29.14% (160.4m / 550.5m)
NOPAT = 449.9m (EBIT 634.9m * (1 - 29.14%))
Current Ratio = 2.15 (Total Current Assets 3.12b / Total Current Liabilities 1.45b)
Debt / Equity = 1.11 (Debt 2.50b / totalStockholderEquity, last quarter 2.26b)
Debt / EBITDA = 2.42 (Net Debt 1.77b / EBITDA 730.4m)
Debt / FCF = 4.30 (Net Debt 1.77b / FCF TTM 411.4m)
Total Stockholder Equity = 2.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.19% (Net Income 371.3m / Total Assets 6.32b)
RoE = 16.63% (Net Income TTM 371.3m / Total Stockholder Equity 2.23b)
RoCE = 14.58% (EBIT 634.9m / Capital Employed (Equity 2.23b + L.T.Debt 2.12b))
RoIC = 9.59% (NOPAT 449.9m / Invested Capital 4.69b)
WACC = 9.61% (E(9.10b)/V(11.6b) * Re(11.59%) + D(2.50b)/V(11.6b) * Rd(3.37%) * (1-Tc(0.29)))
Discount Rate = 11.59% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -83.38 | Cagr: -1.36%
[DCF] Terminal Value 71.61% ; FCFF base≈406.5m ; Y1≈418.7m ; Y5≈466.9m
[DCF] Fair Price = 32.84 (EV 5.95b - Net Debt 1.77b = Equity 4.17b / Shares 127.1m; r=9.61% [WACC]; 5y FCF grow 3.13% → 2.50% )
EPS Correlation: 98.82 | EPS CAGR: 26.10% | SUE: 1.19 | # QB: 1
Revenue Correlation: 88.67 | Revenue CAGR: 3.56% | SUE: 0.24 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.98 | Chg30d=-0.72% | Revisions=-29% | Analysts=11
EPS current Year (2026-12-31): EPS=4.10 | Chg30d=-0.33% | Revisions=+17% | GrowthEPS=+12.7% | GrowthRev=+2.9%
EPS next Year (2027-12-31): EPS=4.62 | Chg30d=-0.59% | Revisions=-50% | GrowthEPS=+12.7% | GrowthRev=+6.9%
[Analyst] Revisions Ratio: -31% (up=3, down=7)